Stock Market & Financial Investment News

News Breaks September 11, 2012 06:19 EDT WPI Watson Pharmaceuticals downgraded to Buy from Conviction Buy at Goldman Goldman removed Watson Pharmaceuticals from its Conviction Buy List due to relative valuation. Price target raised to $95 from $90. News For WPI From The Last 14 Days Check below for free stories on WPI the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. There are no results for WPI Sign up for a free trial to see the rest of the stories you've been missing.